13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


Clinical trials : 3,340 Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05740722
(ClinicalTrials.gov)
March 1, 202330/1/2023Nicotinamide Riboside Supplementation In Progressive Multiple SclerosisNicotinamide Riboside Supplementation In Progressive Multiple Sclerosis: A Randomised Controlled Trial: The NORSEMAN StudyMultiple Sclerosis;Progressive Multiple SclerosisDietary Supplement: Nicotinamid riboside;Dietary Supplement: PlaceboHaukeland University HospitalNULLNot yet recruiting18 Years65 YearsAll300Phase 2Norway
2NCT05046535
(ClinicalTrials.gov)
September 1, 20215/9/2021The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple SclerosisThe Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple SclerosisMultiple SclerosisBehavioral: Sleep quality and physical activity;Genetic: Nicotine dependence;Diagnostic Test: Nicotine and cotinine serum levels;Behavioral: SmokingUniversity of JordanNULLRecruiting18 YearsN/AAll80Jordan